Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
UBS
Express Scripts
AstraZeneca
Federal Trade Commission
Citi
Julphar
Chubb
Cipla
Chinese Patent Office

Generated: October 21, 2017

DrugPatentWatch Database Preview

Deferiprone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for deferiprone and what is the scope of deferiprone patent protection?

Deferiprone
is the generic ingredient in one branded drug marketed by Apopharma Inc and is included in two NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Deferiprone has forty-two patent family members in twenty-four countries.

There are four drug master file entries for deferiprone. One supplier is listed for this compound.

Summary for Generic Name: deferiprone

US Patents:2
Tradenames:1
Applicants:1
NDAs:2
Drug Master File Entries: see list4
Suppliers / Packagers: see list1
Bulk Api Vendors: see list69
Clinical Trials: see list53
Patent Applications: see list936
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:deferiprone at DailyMed

Pharmacology for Ingredient: deferiprone

Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apopharma Inc
FERRIPROX
deferiprone
TABLET;ORAL021825-001Oct 14, 2011RXYesYes► Subscribe► Subscribe► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
TABLET;ORAL021825-001Oct 14, 2011RXYesYes► Subscribe► Subscribe► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
SOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
SOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
TABLET;ORAL021825-001Oct 14, 2011RXYesYes► Subscribe► Subscribe ► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
SOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe ► Subscribe
Apopharma Inc
FERRIPROX
deferiprone
SOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: deferiprone

Country Document Number Estimated Expiration
Hong Kong1130422► Subscribe
Cyprus1116146► Subscribe
Australia2001270402► Subscribe
Spain2539414► Subscribe
European Patent Office2268282► Subscribe
Australia7040201► Subscribe
Eurasian Patent Organization201071235► Subscribe
Hong Kong1152871► Subscribe
Costa Rica11744► Subscribe
Australia2008355464► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Mallinckrodt
QuintilesIMS
Johnson and Johnson
Federal Trade Commission
US Army
Accenture
Fuji
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot